North America Supraglottic Devices Market Outlook (2022-2033)

The North America Supraglottic Devices market size is expected to reach US$ 1,252.6 million by 2033 from US$ 885.8 million in 2025. The market is estimated to record a CAGR of 4.5% from 2026 to 2033.

Executive Summary and North America Supraglottic Devices Market Analysis:

The North America supraglottic devices market is characterized by widespread clinical acceptance and continual innovation, driven by strong healthcare infrastructure and the prioritization of advanced airway management practices across care settings. Supraglottic airway devices are common instruments in anesthesia protocols, emergency rooms, and pre-hospital settings owing to their capacity to offer swift and efficient access to airways without much dependence on complicated intubation procedures. Supraglottic airway devices are now more preferred for regular surgeries, challenging airway management, and emergency situations as they are relatively easy to use and reliable. Health practitioners place much focus on patient safety practices and try to minimize complications during surgery, thereby promoting the use of supraglottic airway devices.

Key factors influencing the market in North America include continuous professional training, solid backing from clinical guidelines, and research and development activities carried out by manufacturers, which result in further enhancements in the safety and convenience features of such products. Such devices have been incorporated into the protocols of emergency medical services and first responders, appreciating their significance when dealing with difficult intubations. However, despite all this positive impact on the market, there are some limitations as well. The regulations of the industry are quite strict, making it essential for new airway management devices to pass through a rigorous clinical trial phase. Additionally, although adoption is high in urban and well-funded healthcare systems, smaller or rural facilities may still favor familiar traditional tools due to entrenched habits or budget considerations.

North America Supraglottic Devices Market - Strategic Insights:

North America Supraglottic Devices Market Segmentation Analysis:

Key segments that contributed to the derivation of the North America Supraglottic Devices market analysis are product type, usage type, application, patient type, and end user.

• By product type, the supraglottic devices market is segmented into laryngeal mask airways, laryngeal tubes, and other product types. The laryngeal mask airways segment dominated the market in 2025.
• Based on usage type, the supraglottic devices market is classified into disposable devices and reusable devices. The disposable devices segment dominated the market in 2025.
• In terms of application, the supraglottic devices market is categorized into anesthesia, critical care, emergency medicine, and other applications. The anesthesia segment dominated the market in 2025.
• By patient type, the supraglottic devices market is bifurcated into adult and pediatric. The adult segment dominated the market in 2025.
• Based on end user, the supraglottic devices market is segmented into hospitals, ambulatory surgical centers, emergency medical services, and other end users. The hospitals segment dominated the market in 2025.

North America Supraglottic Devices Market Drivers and Opportunities:

Shift Toward Minimally Invasive Airway Management Devices

The North America supraglottic devices market is experiencing a clear shift toward minimally invasive airway management devices as healthcare providers prioritize efficiency, safety, and patient comfort. Supraglottic airway devices (SGAs) are increasingly preferred for their rapid deployment and ability to secure airways without requiring highly specialized intubation skills. In high-volume surgical centers and emergency care units, these devices allow clinicians to respond quickly, reducing procedural delays and minimizing complications.

The shift is also influenced by the expanding prevalence of outpatient procedures and shorter hospital stays. SGAs enable faster airway management and reduced anesthesia duration, which supports higher patient throughput and operational efficiency. Hospitals and surgical centers value devices that streamline workflow while maintaining consistent performance, especially in multi-specialty and high-acuity care settings where efficiency and reliability are critical.

Issues related to safety and regulation further add strength to these reasons. The use of disposable SGAs lowers the chances of cross-contamination and infections, whereas innovative designs that increase their sealing capabilities provide patients with greater comfort and ventilatory efficiency. All of these are contributing towards making minimal-invasive airway management devices the future of airway management in North America.

Advancing Adoption of Simulation-Enabled Training Models

Simulation-enabled training models are playing a key role in advancing the adoption of supraglottic airway devices across North America. Healthcare institutions increasingly use high-fidelity simulation programs to train clinicians in safe and effective airway management. These programs allow practitioners to practice device insertion, troubleshoot complications, and develop confidence in a controlled environment, ensuring readiness for real-world emergency and surgical scenarios.

The scenario-based simulation is another integral part of these initiatives that will help to expose the learners to a multitude of patients' situations and SGA options available for treatment. Through the process of training, the protocols can be learned properly, leading to predictable procedure results, as well as improving the teamwork of the involved parties. Simulation helps to improve technical skills and develop judgment abilities in high-pressure situations.

The application of simulation in continuing professional development guarantees competence in performing the procedures and their regular use. There are mobile simulation facilities that make it possible to teach professionals working at either big medical institutions or small offices. The technique will become prevalent among medical professionals in the North American setting.

North America Supraglottic Devices Market Size and Share Analysis:

The North America Supraglottic Devices market demonstrates steady growth, with size and share analysis highlighting evolving trends and competitive dynamics among key players. The report evaluates important subsegments categorized within product type, usage type, application, patient type, and end user, highlighting their respective contributions to overall market performance.

By product type, the laryngeal mask airways subsegment dominated the supraglottic devices market in 2025. The dominance of laryngeal mask airways is driven by their ease of insertion, high success rate in securing the airway, reduced risk of complications compared to traditional intubation, and broad adoption in surgical and emergency settings, making them a key revenue contributor for manufacturers.

Based on usage type, the disposable devices subsegment led the market in 2025. Disposable supraglottic devices are preferred due to their reduced risk of cross-contamination, lower sterilization requirements, and convenience for high-volume clinical environments, which supports their widespread adoption across hospitals and emergency care facilities.

In terms of application, the anesthesia subsegment dominated the market in 2025. This leadership is attributed to the frequent use of supraglottic devices in elective and emergency surgical procedures, the increasing number of surgeries worldwide, and the clinical benefits of providing a safe and effective airway without the need for invasive intubation.

By patient type, the adult subsegment dominated the market in 2025. The preference for adult patients is driven by higher procedural volumes in adult surgeries, the established clinical efficacy of supraglottic devices in adult airway management, and increasing adoption in critical care and emergency settings.

Based on end user, the hospitals subsegment dominated the market in 2025. Hospitals lead due to their well-established anesthesia and critical care departments, access to advanced airway management devices, trained staff, and the capability to perform a high volume of surgical and emergency procedures requiring reliable airway management.

North America Supraglottic Devices Market Report Highlights:

North America Supraglottic Devices Market Report Coverage and Deliverables:

The "North America Supraglottic Devices Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• North America Supraglottic Devices market size and forecast at regional and country levels for all market segments covered under the scope
• North America Supraglottic Devices market trends, as well as drivers, restraints, and opportunities
• North America Supraglottic Devices market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the North America Supraglottic Devices market
• Detailed company profiles, including SWOT analysis

North America Supraglottic Devices Market Geographic Insights:

The geographical scope of the North America Supraglottic Devices market report is divided into: The US, Canada, and Mexico. The US held the largest share in 2025.

The US leads in the North America supraglottic devices market due to the high level of sophistication of its healthcare system, together with its clinical focus on superior airway management. Supraglottic airway devices have been extensively used in the US within operating theaters for general anesthesia and in emergencies and critical care units, where immediate control of the airway is essential. Physicians specializing in anesthesiology, emergencies, and critical care frequently work together to optimize airway management techniques, ensuring that these devices are embraced as dependable replacements for endotracheal intubation whenever appropriate.

This implementation process has been augmented by rigorous training of clinicians, simulations, and the suggestions made by professional societies about the need for supraglottic devices to enhance patient safety and simplify the procedure. The EMS teams in many states have also adopted the use of supraglottic airway devices in pre-hospital environments where difficult intubations are possible. The American healthcare sector is further assisted by its highly competitive medical equipment manufacturing companies that consistently innovate new product designs emphasizing user-friendliness, comfort, and prevention of infections. Although cost factors play a role in determining procurement, the prevailing focus on quality care makes sure that supraglottic devices remain integral in practice.

North America Supraglottic Devices Market Research Report Guidance:

• The report includes qualitative and quantitative data in the North America Supraglottic Devices market across product type, usage type, application, patient type, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the North America Supraglottic Devices market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the North America Supraglottic Devices market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the North America Supraglottic Devices market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 12 cover North America Supraglottic Devices market segments by product type, usage type, application, patient type, end user, and geography across The United States, Canada and Mexico. They cover the market revenue, forecast, and factors driving the market.
• Chapter 13 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 14 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 15 provides detailed profiles of the major companies operating in the North America Supraglottic Devices market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 16, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

North America Supraglottic Devices Market News and Key Development:

The North America Supraglottic Devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the North America Supraglottic Devices market are:

• In December 2025, Ambu A/S expanded its airway device offerings in North America with the introduction of the Ambu SureSight Mobile video laryngoscope (a mobile version of its airway visualization tools) targeting emergent and pre‑hospital airway management environments across the US a notable portfolio expansion in the clinical airway category served by supraglottic and related devices.
• In January 2025, Ambu A/S announced the launch of its new Ambu SureSight Connect video laryngoscopy solution in the United States, expanding its airway visualization product portfolio; while this product is a video laryngoscope rather than a supraglottic device itself, it complements supraglottic airway management workflows and represents a strategic airway product rollout in North America.

Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• Food and Drug Administration (FDA)
• European Database on Medical Devices (EUDAMED)
• European Society of Cardiology (ESC)
• American College of Cardiology (ACC)
• American Heart Association (AHA)
• Company Websites
• Company Annual Reports
• Company Investor Presentations